Thermogen Country Lemonade
98/100
This product looks safe
- Kava (Piper methysticum) extract: 400mg is 1.6× the Tolerable Upper Intake Level (250mg)
- 47% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Kava (Piper methysticum) extract: 400mg is 1.6× the Tolerable Upper Intake Level (250mg)
Label Data
13.1 Gram(s)
Serving Size
20
Servings
Other Combinations
Product Type
47%
Evidence Coverage
Supplement Facts — Evidence Check
2000 mg
📊 Market median: 500.0mg (223 products)
📚 22 studies (Tier A: 0, B: 1)
2000 mg
📊 Market median: 500.0mg (861 products)
📚 60 studies (Tier A: 4, B: 13)
2000 mg
📊 3.6× RDA — above typical dose (UL: 3500 mg)
📚 36 studies (Tier A: 1, B: 7)
1667 mg
📊 Market median: 600.0mg (321 products)
📚 5 studies — no high-quality reviews
Yerba Mate (Ilex paraguanensis) (leaf) powder
1500 mg
Phenylethylamine
500 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.6× (UL: 250 mg)
📚 12 studies (Tier A: 0, B: 5)
Cocoa extract
400 mg
400 mg
📊 Market median: 180.0mg (239 products)
📚 43 studies (Tier A: 1, B: 19)
200 mg
📊 Market median: 200.0mg (358 products)
📚 9 studies (Tier A: 0, B: 2)
📊 Market median: 983.0mg (16 products)
📚 7 studies (Tier A: 0, B: 1)
📊 Market median: 496.0mg (192 products)
📚 20 studies — no high-quality reviews
AstraGin
50 mg
Bioperine Nature's Thermonutrient
5 mg
Rauwolfia vomitoria root bark extract
2.5 mg
Label Claims — Verification
❓
Structure/Function
All Other (98% of products)
Structure/Function (78% of products)
Nutrient (56% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
🧪 Formulation Notes
Pre-cardio powerhouse Fat loss Energy Motivation
Product Details
DSLD Entry Date
2020-04-23
Product Type
Other Combinations
Form
Powder
Brand
MN Morphogen Nutrition
DSLD ID
218306
Data Updated
2026-04-11
Research Evidence
50
Research Sources
47
Avg Quality Score
28
Rct
13
Clinical Trial
5
Guideline
4
Systematic Review
A
Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
B
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
B
Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
B
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
B
[Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
B
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
B
Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
C
Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Compare Similar Products
Pure L-Tyrosine Free Form Amino Powder
Hard Rhino
100
100% Pure L-Tyrosine
NutraBio
100
N-Acetyl L-Tyrosine
NutraBio
100
N-Acetyl L-Tyrosine
NutraBio
100
L-Tyrosine
Hard Rhino
100